Hints and tips:
...Pharma too. Switch to utilities, they reckon....
...We value IAG at a P/B 2019 of 0.4x (as for AF-KLM / at a 20% discount to Lufthansa’s P/B multiple in the lows in 2009; IAG was formed in 2011)....
...We can move faster than pharma.” Hope for sickle cell Victoria Gray had been ill for all of her 34 years....
...(FT) Big Tech v Big Pharma Critics fear Silicon Valley lobbying has weakened the defence of intellectual property and sapped innovation. Rana Foroohar reports....
...UK drugmaker AstraZeneca is in talks to acquire cancer drug developer Acerta Pharma, possibly for more than $5bn....
...AstraZeneca has agreed to buy a majority stake in Acerta Pharma with an option to take full control for up to $7bn, capping an intense period of dealmaking for the UK group as it races to refill its drugs...
International Edition